Epigenetic mechanisms may play an important role in the etiology of endometriosis. The modification of histones by methylation of lysine residues has been shown to regulate gene expression by changing chromatin structure. We have previously shown that endometriotic lesions had aberrant levels of histone acetylation (lower) and methylation (higher) than control tissues. We aimed to determine the levels of trimethylated histone 3 at lysine residue 27 (H3K27me3), a well-known repressive mark, by immunoassay of fresh tissues and immunohistochemistry (IHC) of an endometriosis-focused tissue microarray. Also, we aimed to determine levels of expression of enhancer of zeste homolog 2 (EZH2), the enzyme responsible for trimethylation of H3K27me3, in cell lines. Average levels of H3K27me3 measured by immunoassay were not significantly different in lesions compared to endometrium from patients and controls. However, there was a trend of higher levels of H3K27me3 in secretory versus proliferative endometrium. The results of IHC showed that lesions (ovarian, fallopian, and peritoneal) and secretory endometrium from controls have higher percentage of H3K27me3-positive nuclei than eutopic endometrium from patients. Endometriotic epithelial cells express high levels of EZH2, which is upregulated by progesterone. This study provides evidence in support of a role of H3K27me3 in the pathogenesis of endometriosis and for EZH2 as a potential therapeutic target for this disease, but more studies are necessary to understand the molecular mechanisms at play.
GiudiceLC.Clinical practice. Endometriosis. N Engl J Med. 2010;362(25):2389–2398.
2.
GuoSW. Epigenetics of endometriosis. Mol Hum Reprod. 2009;15(10):587–607.
3.
ZhaoMTangQWuWXiaYChenDWangX. miR-20a contributes to endometriosis by regulating NTN4 expression. Mol Biol Reprod. 2014;41(9):5793–5797.
4.
BurneyOGiudiceLC. Pathogenesis and pathophysiology of endometriosis. Fertil Steril. 2012;98(3):511–519.
5.
BulunSE.Mechanisms of Disease: Endometriosis. N Engl J Med. 2009;360(3):268–279.
6.
MunroSKFarquharCMMitchellMDPonnampalamAP. Epigenetic regulation of the endometrium during the menstrual cycle. Mol Hum Reprod. 2010;16(5):297–310.
7.
ForteACipollaroMGalderisiU. Genetic, epigenetic and stem cell alterations in endometriosis: new insights and potential therapeutic perspectives. Clin Sci. 2014;126(2):123–138.
8.
BannisterAJKouzaridesT. Regulation of chromatin by histone modifications. Cell Res. 2011;21(3):381–395.
9.
TangHAnSZhenHChenF. Characterization of combinatorial histone modifications on lineage-affiliated genes during hematopoietic stem cell myeloid commitment. Acta Biochem Biophys Sin (Shangai). 2014;46(10):894–901.
10.
ZhangXWenHShiX. Lysine methylation: beyond histones. Acta Biochem Biophys Sin. 2012;44(1):14–27.
11.
KimJKimH. Association between endometriosis and polymorphisms in insulin-like growth factor binding protein genes in Korean women. Eur J Obstet Gynecol Reprod Biol. 2012;162(1):96–101.
12.
BenoitYDLaursenKBWitherspoonMSLipkinSMGudasLJ. Inhibition of PRC2 histone methyltransferase activity increases TRAIL-mediated apoptosis sensitivity in human colon cancer. J Cell Physiol. 2013;228(4):764–772.
13.
LiHCaiQGodwinAKZhangR. Enhancer of zeste homolog 2 (EZH2) promotes the proliferation and invasion of epithelial ovarian cancer cells. Mol Cancer Res. 2010;8(12):1610–1618.
14.
RogenhoferSKahlPMertensC. Global histone H3 lysine 27 (H3K27me) methylation levels and their prognostic relevance in renal cell carcinoma. BJU Int. 2012;109(3):459–465.
15.
VennetiSSantiMFelicellaMM. A sensitive and specific histopathologic prognostic marker for H3F3A K27 M mutant pediatric glioblastomas. Acta Neuropathol. 2014;128(5):743–753.
16.
Colon-DiazMBaez-VegaPGarciaM. HDAC 1 and HDAC 2 are differentially expressed in endometriosis. Reprod Sci. 2012;19(5):483–492.
17.
MonteiroJColon-DiazMGarciaM. Endometriosis is chracterized by a distinct pattern of histone 3 and histone 4 lysine modifications. Reprod Sci. 2014;21(3):305–318.
18.
DingDLiuXGuoSW. Overexpression of lysine-specific demethylases 1 in ovarian endometriomas and its inhibition reduces cellular proliferation, cell cycle progression, and invasiveness. Fertli Steril. 2014;101(3):740–749.
19.
NoyesRWHertigATRockJ. Dating the endometrial biopsy. Am J Obstet Gynecol. 1975;122(2):262–263.
20.
ZeitvogelABaumannRStarzinski-PowitzA. Identification of an invasive, N-cadherin-expressing epithelial cell type in endometriosis using a new cell culture model. Am J Pathol. 2001;159(5):1839–1852.
21.
KimJTaylorHLuZ. Altered expression of HOXA10 in endometriosis: potential role in decidualization. Mol Hum Reprod. 2007;13(5):323–332.
22.
WuYStrawnEBasirZHalversonGGuoSW. Promoter hypermethylation of progesterone receptor B (PR-B) in endometriosis. Epigenetics. 2006;1(2):106–111.
23.
GuoSW. The endometrial epigenome and its response to steroid hormones. Mol Cell Endocrinol. 2012;358(2):185–189.
24.
KuMKocheRCowanRE. Genomewide analysis of PRC1 and PRC2 occupancy identify two classes of bivalent domains. PLoS Genet. 2008;4(10):e1000242.
25.
XuCRLiLCDonahueG. Dynamics of genomic H3K27me3 domains and role of EZH2 during pancreatic endocrine specification. EMBO J. 2014;33(19):2157–2170.
26.
ShpargelKBStarmerJYeeDPohlersMMagnusonT. KDM6 demethylase independent loss of histone 3 lysine 27 trimethylation during Early Embryonic Development. PLoS Genet. 2014;10(8):e1004507.
27.
BogliottiYSRossPJ. Mechanisms of histone H3 lysine 27 trimethylation remodeling during early mammalian development. Epigenetics. 2012;7(9):976–981.
28.
GrimaldiGChristianMSteelJHHenrietPPoutanenMBrosensJJ. Down-regulation of the histone methyltransferase EZH2 contributes to the epigenetic programming of decidualizing human endometrial stromal cells. Mol Endocrinol J. 2011;25(11):1892–1903.
29.
FelicianGCollesiCLusicM. Epigenetic modification at Notch Receptor promotes blunts efficacy of inducing Notch Pathway reactivation after myocardial infarction. Circ Res. 2014;115(7):636–649.
30.
YamaguchiHHungMC. Regulation and Role of EZH2 in Cancer. Cancer Res Treat. 2014;46(3):209–222.
31.
GreerELShiY. Histone methylation: a dynamic mark in health, disease and inheritance. Nature. 2012;13(5):343–357.
32.
ChinaranagariSSharmaPChaudharyJ. E EZH2 dependent H3K27me3 is involved in epigenetic silencing of ID4 in prostate cancer. Oncotarget. 2014;5(16):7172–7182.
33.
TanDTanSZhangJ. Histone Trimethylation of the p53gene by expression of a constitutively active prolactin receptor in prostate cancer cells. Chin J Physiol. 2013;56(5):282–290.
34.
LuCHanHDMangalaLS. Regulation of tumor angiogenesis by EZH2. Cancer Cell. 2010;18(2):185–197.
35.
CaoQYuJDhanasekaranSM. Repression of E-cadherin by the Polycomb Group Protein EZH2 in Cancer. Oncogene. 2008;27(58):7274–7284.
36.
XuCHouZZhanP. EZH2 promotes tumor cell migration and invasion via epigenetic repression of E-cadherin in renal cell carcinoma[published online February 25, 2014]. BJU Int. 2014.
37.
LiuLXuZZhongL. EZH2 regulates cancer cell migration through repressing TIMP-3 in non-small cell lung cancer. Med Oncol. 2013;30(4):713.
38.
AuSLWongCCLeeJMWongCMNgIO. EZH2-Mediated H3K27me3 is involved in epigenetic repression of deleted in liver cancer 1 in human cancers. Plos One. 2013;8(6):e68226.
39.
GaoSBZhengQFXuB. EZH2 represses target genes through H3K27-dependent and H3K27-independent mechanisms in hepatocellular carcinoma. Am Assoc Cancer Res. 2014;12(10):1388–1397.
40.
GaoFJiGGaoZ. Direct ChIP-bisulfite sequencing reveals a role of H3K27me3 mediating aberrant hypermethylation of promoter CpG islands in cancer cells. Cell Biochem Biophys. 2014;103(2–3):204–210.
41.
LiHBitlerBVathipadiekalV. ALDH1A1 is a novel EZH2 target gene in epithelial ovarian cancer identified by genome-wide approaches. Cancer Prev Res. 2012;5(3):484–491.
42.
FuYChenJPangBLiCZhaoJShenK. EZH2-induced H3K27me3 is associated with epigeentic repression of the ARH1 tumor suppressor gene in ovarian cancer. Cell Biochem Biphys. 2015;71(1):105–112.
CowardWRFeghali-BostwickCAJenkinsGKnoxAJPangL. A central role for G9a and EZH2 in the epigenetic silencing of cyclooxygenase-2 in idiopathic pulmonary fibrosis. FASEB J. 2014;28(7):3183–3196.
